In SURMOUNT-1, nausea occurred in 24.6% of participants on 5mg, 33.3% on 10mg, and 31.0% on 15mg
Tirzepatide is a 39amino acid dual incretin receptor agonist that activates both GLP1 and GIP receptors, enhancing glucosedependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2]
Faster tendon healing in animal models Journal of Applied Physiology, 2011 Knee pain relief in human patients Journal of Orthopaedic Surgery and Research, 2021 Safety profile across soft tissue indications Current Pharmaceutical Design, 2019 The statements on this page have not been evaluated by the Food and Drug Administration
The benzyl alcohol component helps inhibit bacterial growth, allowing for multiple withdrawals from a single vial when proper aseptic techniques are followed
Researchers working with lyophilised peptide compounds frequently incorporate bacteriostatic water as part of reconstitution protocols within peptide laboratory applications and compound stability assessments conducted under appropriate in-vitro research environments